Related Experiment Videos
Cancer epigenetics: DNA methylation and chromatin alterations in human cancer
1Cancer Epigenetics Laboratory, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.
Abstract:
Aberrations in the DNA methylation patterns are nowadays recognized as a hallmark of human cancer. One of the most characteristic changes is the hypermethylation of CpG islands of tumor suppressor genes associated with their transcriptional silencing. The target genes are distributed in all cellular pathways (apoptosis, DNA repair, cell cycle, cell adherence, etc.). They are "classical" tumor suppressor genes with associated familial cancers (BRCA1, hMLH1, p16INK4a, VHL, etc.) and putative new tumor suppressor genes which loss may contribute to the transformed phenotype (MGMT, p14ARF, GSTP1, RARB2, etc.). A tumor-type specific profile of CpG island hypermethylation exist in human cancer that allows the use of these aberrantly hypermethylated loci as biomarkers of the malignant disease. The eruption of new technologies for the careful study of the DNA methylation patterns, and their genetic partners in accomplishing gene silencing, it may also provide us with new drugs for the epigenetic treatment of human tumors.
Insights
DNA methylation pattern aberrations are key cancer indicators. Hypermethylation of tumor suppressor genes silences them, offering potential biomarkers and epigenetic treatment targets.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aberrant DNA methylation, particularly CpG island hypermethylation, is a recognized hallmark of human cancers.
- This hypermethylation leads to transcriptional silencing of critical tumor suppressor genes involved in various cellular pathways.
- These genes include both classical tumor suppressors linked to familial cancers and novel ones contributing to the transformed phenotype.
Purpose of the Study:
- To highlight the significance of DNA methylation aberrations in cancer development.
- To emphasize the role of CpG island hypermethylation in tumor suppressor gene silencing.
- To explore the potential of these methylation patterns as cancer biomarkers and therapeutic targets.
Main Methods:
- Review of current understanding of DNA methylation patterns in cancer.
- Analysis of gene silencing mechanisms involving hypermethylated CpG islands.
- Identification of specific tumor suppressor genes affected by these aberrations.
Main Results:
- A distinct, tumor-type specific profile of CpG island hypermethylation exists in human cancers.
- Aberrantly hypermethylated loci can serve as reliable biomarkers for malignant diseases.
- Advancements in methylation analysis technologies are paving the way for new epigenetic therapies.
Conclusions:
- DNA methylation patterns are crucial in cancer biology, acting as both drivers and indicators.
- Hypermethylated tumor suppressor genes offer diagnostic and prognostic value.
- Emerging technologies promise novel epigenetic treatments for human tumors.